SCHEMBL7165995

SCHEMBL7165995

CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1N=NC1C(=O)N(c2ccc(Cl)c(Cl)c2)N=C1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ LMNA P02545 3/20 0.48
▸ TDP1 Q9NUW8 3/20 0.48
▸ NPC1 O15118 2/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ MEN1 O00255 5/20 0.47
▸ KMT2A Q03164 5/20 0.47
▸ CYP2C9 P11712 2/20 0.45
▸ HTT P42858 2/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ POLB P06746 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ PDE5A O76074 1/20 0.43
▸ ATM Q13315 1/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7165991 1.00 MAPT (0.48) MAPTSMN1; SMN2ALDH1A1LMNATDP1
SCHEMBL7165988 1.00 MAPT (0.48) MAPTSMN1; SMN2ALDH1A1LMNATDP1
SCHEMBL5202737 0.86 MAPT (0.50) MAPTSMN1; SMN2ALDH1A1LMNATDP1
SCHEMBL5206340 0.86 MAPT (0.50) MAPTSMN1; SMN2ALDH1A1LMNATDP1
SCHEMBL5206330 0.86 MAPT (0.50) MAPTSMN1; SMN2ALDH1A1LMNATDP1
SCHEMBL7178572 0.83 MAPT (0.43) MAPTSMN1; SMN2ALDH1A1LMNATDP1
SCHEMBL5204074 0.83 MAPT (0.52) MAPTSMN1; SMN2ALDH1A1LMNATDP1
SCHEMBL5204078 0.83 MAPT (0.52) MAPTSMN1; SMN2ALDH1A1LMNATDP1
SCHEMBL5204527 0.81 MAPT (0.50) MAPTSMN1; SMN2ALDH1A1LMNATDP1
SCHEMBL5204522 0.81 MAPT (0.50) MAPTSMN1; SMN2ALDH1A1LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6552008-B1 Administering effective amount of a selected azo-pyrazole derivative for therapy of thrombocytopenia SMITHKLINE BEECHAM CORPORATION 2003-04-22 — — US disclosed
Send feedback